The purpose of this study is to assess safety and efficacy of autologous chondrocyte implantation delivered arthroscopically into chondral lesions of the knee using clinical, biochemical, and MRI outcomes.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from baseline to different periods in T2 Mapping for cartilage lesions after treatment.
Timeframe: 3, 6, 9, 12, 18, 24 36 months